We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Adenoviral-mediated, intratumor gene transfer of interleukin 23 induces a therapeutic antitumor response.
- Authors
Reay, J; Kim, S-H; Lockhart, E; Kolls, J; Robbins, P D
- Abstract
Interleukin 23 (IL-23) is a member of the IL-12 family of heterodimeric cytokines, composed of p19 and p40 subunits, which exhibits immunostimulatory properties similar to IL-12. IL-23 has been shown to possess potent antitumor activities in several establishment models of cancer and a few therapeutic models, but the efficacy of local, adenoviral-mediated expression of IL-23 in established tumors has yet to be investigated. Here we have examined the antitumor activity of adenovirally delivered IL-23 in a day-7 MCA205 murine fibrosarcoma tumor model. Three intratumoral injections of adenovirus expressing IL-23 (Ad.IL-23) significantly increased animal survival and resulted in complete rejection of 40% of tumors, with subsequent generation of protective immunity and MCA205-specific cytotoxic T lymphocytes. In addition, we have shown that the antitumor activity of IL-23 is independent of IL-17, perforin and Fas ligand, but dependent on interferon-gamma, CD4(+) and CD8(+) T cells. These results demonstrate that direct intratumoral injection of adenovirus expressing IL-23 results in enhanced survival, tumor eradication and generation of protective immunity by generation of a Th1-type immune response.
- Publication
Cancer gene therapy, 2009, Vol 16, Issue 10, p776
- ISSN
1476-5500
- Publication type
Journal Article
- DOI
10.1038/cgt.2009.27